About Orphidia
Orphidia is a Healthcare company based in San Francisco (United States) founded in 2013. Handheld device for point-of-care chronic disease diagnostics is developed. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Screening. Its competitors include CellScope, Nuclein and Mel-Mont Medical; 3 of its 3 listed competitors have raised funding.
Company details
Orphidia is a handheld point-of-care diagnostic device that tests for a number of chronic diseases. The device works like a glucometer, a fast prick on the finger and it runs multiple tests on a single, replaceable cartridge. The diagnostic results are shown in a smartphone app. Users can follow the progression of a specific disease; or track their overall fitness and understand how their lifestyle changes this risk. Users can also share this data with their doctor through an export to EHR feature. The company claims that it can run upto 50 tests in under 20 minutes on a single drop of blood, including test panels for liver, kidney, cardiac and thyroid function, in addition to electrolyte, hormone and vitamin levels.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Website orphidia.com
- Social LinkedIn X
People of Orphidia
4 people are tracked at Orphidia (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Jared Slosberg | Co-founder & Executive Chairman | Leadership |
Gregory Harriman M.d. | Director | Leadership |
Nan Wang | Director of China Business Development | Leadership |
Lizette Ndimuntoh | Bioassay R&d Technician | Team |
Complete people profiles for Orphidia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Orphidia
Orphidia has 3 listed competitors in our database, 3 of them funded. They include CellScope, Nuclein and Mel-Mont Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellscope.com | 2010 | San Francisco, United States | $4.62M | In-ear visibility is enabled by smartphone-attached otoscope for at-home diagnosis. | ||
| nuclein.com | 2017 | Austin, United States | $18.97M | Handheld PCR devices for infectious disease detection are developed. | ||
| mel-montmedical.com | 2014 | Doral, United States | $3M | Molecular screening devices for early infectious disease detection are developed. |
Detailed competitors of Orphidia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Orphidia (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orphidia
Orphidia was founded in 2013.
Orphidia is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Orphidia is a handheld point-of-care diagnostic device that tests for a number of chronic diseases. The device works like a glucometer, a fast prick on the finger and it runs multiple tests on a single, replaceable cartridge. The diagnostic results are shown in a smartphone app. Users can follow the progression of a specific disease; or track their overall fitness and understand how their lifestyle changes this risk. Users can also share this data with their doctor through an export to EHR feature. The company claims that it can run upto 50 tests in under 20 minutes on a single drop of blood, including test panels for liver, kidney, cardiac and thyroid function, in addition to electrolyte, hormone and vitamin levels.
Orphidia's top competitors include Nuclein, CellScope and Mel-Mont Medical.